Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway

BACKGROUND: Therapeutic hypothermia is a treatment modality that is increasingly used to improve clinical neurological outcomes for ischemia-reperfusion injury-mediated diseases. Antibody-initiated classical complement pathway activation has been shown to contribute to ischemia-reperfusion injury in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Tushar A, Mauriello, Clifford T, Hair, Pamela S, Sandhu, Amandeep, Stolz, Michael P, Bass, William Thomas, Krishna, Neel K, Cunnion, Kenji M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079622/
https://www.ncbi.nlm.nih.gov/pubmed/24962100
http://dx.doi.org/10.1186/1479-5876-12-181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079622/
https://www.ncbi.nlm.nih.gov/pubmed/24962100
http://dx.doi.org/10.1186/1479-5876-12-181

Ejemplares similares